Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Multiple-Ascending Dose Study in Type 2 Diabetes Mellitus Patients

This study has been completed.
Information provided by:
Eli Lilly and Company Identifier:
First received: December 1, 2010
Last updated: June 9, 2011
Last verified: June 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2011
  Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)